#Ischemia-reperfusion
A great Chemical Science
by Jihong Liu "A multifunctional “three-in-one” fluorescent theranostic system for hepatic ischemia–reperfusion injury" doi.org/10.1039/D4SC...
A multifunctional “three-in-one” fluorescent theranostic system for hepatic ischemia–reperfusion injury
Hepatic ischemia–reperfusion injury (HIRI) is the main cause of postoperative liver dysfunction and liver failure. Traditional separation of HIRI diagnosis and therapy confers several disadvantages, i...
doi.org
November 18, 2024 at 2:59 PM
Hier übrigens mal die ellenlange skills-and-expertise-Liste von Herrn Kleinschnitz. Quelle: ResearchGate

LongCovid sehe ich hier nicht.

PS: Der Nobelpreisträger, mit dem ich drei Papers veröffentlichte, sagte immer:
„Wer sich in mehr als 20 Themen als Experte darstellt, ist unseriös!“
November 23, 2025 at 5:00 PM
first result of our 18 color imaging of immune populations in lungs following is ischemia+reperfusion injury 🤩
November 20, 2024 at 11:31 PM
Severe ischemia-reperfusion injury induces epigenetic inactivation of LHX1 in kidney progenitor cells after kidney transplantation.👩‍🔬🥼👨‍🔬🧪 #KidneyDisease #Transplant #NephSeq #Epigenetics #Ischemia

👇👇

www.amjtransplant.org/article/S160...
Severe ischemia-reperfusion injury induces epigenetic inactivation of LHX1 in kidney progenitor cells after kidney transplantation
Severe ischemia-reperfusion injury (IRI) causes acute and chronic kidney allograft damage. As therapeutic interventions to reduce damage are limited yet, research on how to promote kidney repair has g...
www.amjtransplant.org
November 23, 2024 at 10:08 AM
A 5-day protocol to generate hiPSC 3D Vascular Organoid😎
ETV2▶️Endothelial Cell
NKX3.1▶️Mural Cell

👉Perfusable, arteriovenous network in vivo
👉⏫Reperfusion in mouse diabetic limb ischemia
👉⏫transplanted islet performance

@meleromartinlab.bsky.social #CellStemCell 2025
www.cell.com/cell-stem-ce...
December 14, 2025 at 12:53 PM
OK BUT WAIT

I STARTED MY AMARO ADVENTURE BECAUSE OF A SAFFRON AMARO AND HOW IT SEEMED TO HELP ME WALK BETTER
March 20, 2026 at 8:55 PM
New in peptide research: "BPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence" (International journal of molecular sciences)
https://pubmed.ncbi.nlm.nih.gov/42794771/
#peptides #research
September 28, 2026 at 11:00 PM
Sirt5 preserves cardiac function in ischemia-reperfusion injury by inhibiting ANT2 lactylation https://www.biorxiv.org/content/10.1101/2024.11.25.625148v1
Sirt5 preserves cardiac function in ischemia-reperfusion injury by inhibiting ANT2 lactylation https://www.biorxiv.org/content/10.1101/2024.11.25.625148v1
Myocardial ischemia-reperfusion (IR) injury is the most common type of heart disease. IR-disrupted m
www.biorxiv.org
November 26, 2024 at 4:00 PM
Spatial metabolomics reveals persistent localized niche-specific metabolic failure in kidneys following ischemia-reperfusion injury https://www.biorxiv.org/content/10.1101/2025.05.27.656326v1
June 1, 2025 at 7:45 PM
Orally Delivered Milk-Derived Nanovesicles Loaded with Connexin 43 Peptides forTargeted Cardiac Ischemia-Reperfusion Therapy https://www.biorxiv.org/content/10.1101/2025.01.01.630994v1
January 2, 2025 at 6:46 PM
🫁 Could Maresin1 help protect transplanted lungs? This study found that Maresin1 reduced lung ischemia-reperfusion injury in a model by suppressing ferroptosis through PKA-Hippo-YAP signaling.
www.mdpi.com/2227-9059/13...
September 28, 2026 at 8:23 AM
New Study in Biomedicines!🚀 This study explored early vs. delayed meloxicam treatments in renal ischemia–reperfusion injury, highlighting key cell death pathways and ERK1/2 phosphorylation
www.mdpi.com/2227-9059/14...
September 28, 2026 at 8:23 AM
ILC1 protect liver transplants from ischemia-reperfusion injury via IFN-γ
doi.org/10.1016/j.aj...
December 31, 2024 at 2:51 PM
HA-fa KÓ-schíí! Mjeeg gokkt KÓ-schíí.

Með öðrum orðum: Gera eins og litli Daði segir. Hafa kósí. Mjög gott kósí.

Breyta myrkri í stjörnur og kulda í heitan pott. Beita markvissum tæknilegum aðgerðum til að valda oxýtósínseytingu—kúri og söng—af því oxýtósín er bólgueyðandi.
Oxytocin ameliorates ischemia/reperfusion-induced injury by inhibiting mast cell degranulation and inflammation in the rat heart
Oxytocin (OT) has shown a cardioprotective effect on myocardial ischemia/reperfusion injury (MIRI). This study aimed to investigate whether the cardio…
www.sciencedirect.com
October 1, 2024 at 7:55 AM
🚨Looking to recruit a postdoc chemist/chemical biologist to join an exciting translational collaboration. Funded by Kidney Research UK we aim to develop new peptide-based therapeutics to alleviate innate immune complications in transplanted kidneys through preventing ischemia-reperfusion injury.🚨
December 17, 2024 at 4:10 PM
IMM protein ANT2 lactylation!!!

Sirt5 preserves cardiac function in ischemia-reperfusion injury by inhibiting ANT2 lactylation
November 26, 2024 at 4:17 PM
Excited to share that at the annual MRC MBU symposium I was awarded best poster prize for my PhD project on Succinate Metabolism in Cardiac Ischemia/ Reperfusion Injury! Thanks to my lab, collaborators, and my PI Mike Murphy. @mitoredox.bsky.social
October 20, 2025 at 1:58 PM
Bears parallels to weaning of cardiopulmonary bypass after resuscitation of the heart following ischemia-reperfusion damage. Some things take time.
June 10, 2025 at 5:38 AM
Fibrillar collagen probe CNA35-Cy7 i.v. to monitor mouse kidney #Fibrosis (ischemia-reperfusion injury)

Can it be used for other organs in vivo?😄

#KidneyInt 2020
www.sciencedirect.com/science/arti...
May 8, 2024 at 3:52 AM
CD94-targeted depletion reduces NK cells and attenuates mouse kidney ischemia-reperfusion injury and subsequent acute lung injury
www.sciencedirect.com/science/arti...
September 9, 2026 at 3:13 PM
Mitochondria transplantation holds promise for ischemia-reperfusion injury (>3M patients/yr).

cellvie + @csem.ch built an automated, standardized process—GMP-compliant + ready for CDMO transfer.

Phase I prep underway.

🔬 Thoughts from the #biotech / #celltherapy community?
📖 bit.ly/4mL5E7u
CSEM and cellvie bring mitochondria treatment one step closer to the clinic
cellvie and CSEM develop automated manufacturing for mitochondrial therapy, aiming to advance treatment of ischemia-reperfusion injury and benefit over 3 million patients annually.
bit.ly
September 3, 2025 at 7:47 AM